UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 1, 2019
Science Applications International Corporation
(Exact name of registrant as specified in its charter)
Delaware | 001-35832 | 46-1932921 | ||
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
12010 Sunset Hills Road Reston, Virginia | 20190 | |
(Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code: (703)676-4300
Not Applicable
(Former Name or former address if changed since last report.)
Check the appropriate box below if the Form8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ | Soliciting material pursuant to Rule14a-12 under the Exchange Act (17 CFR240.14a-12) |
☐ | Pre-commencement communications pursuant to Rule14d-2(b) under the Exchange Act (17 CFR240.14d-2(b)) |
☐ | Pre-commencement communications pursuant to Rule13e-4(c) under the Exchange Act (17 CFR240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
Common Stock, par value $0.0001 per share | SAIC | New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) orRule 12b-2 of the Securities Exchange Act of 1934(§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 7.01. | Regulation FD Disclosure. |
On July 2, 2019, Science Applications International Corporation (the “Company”) issued a press release announcing the events discussed in Item 8.01 below, the text of which is furnished as Exhibit 99.1 hereto and incorporated herein by reference. The information contained in this Item 7.01 and Exhibit 99.1 is being furnished, and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under Section 18. Furthermore, the information contained in this Item 7.01 and Exhibit 99.1 shall not be deemed to be incorporated by reference into the Company’s filings under the Securities Act of 1933, as amended, or the Exchange Act.
Item 8.01. | Other Events. |
On July 1, 2019, the Company entered into a Share Repurchase Agreement (the “Share Repurchase Agreement”) with Kohlberg Kravis Roberts & Co. L.P. (“KKR”). Pursuant to the Share Repurchase Agreement, the Company repurchased an aggregate of 1,168,498 shares of its common stock, par value $0.0001 per share (the “Common Stock”), owned by KKR, in a private transaction at a purchase price equal to $85.58 per share of Common Stock (the “Share Repurchase”). The Company funded the Share Repurchase with cash on hand and incremental borrowings under its existing revolving credit facility. The Share Repurchase is expected to close on July 2, 2019, subject to customary conditions.
The foregoing description of the Share Repurchase Agreement is not complete and is subject to, and qualified in its entirety by, the full text of the Share Repurchase Agreement, which is attached as Exhibit 10.1 to this Current Report on Form8-K and incorporated herein by reference.
Item 9.01. | Financial Statements and Exhibits. |
(d) Exhibits.
Exhibit | Description of Exhibit | |
10.1 | Share Repurchase Agreement, dated July 1, 2019, between Science Applications International Corporation and Kohlberg Kravis Roberts & Co. L.P. | |
99.1 | Press Release, dated July 2, 2019. |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
SCIENCE APPLICATIONS INTERNATIONAL CORPORATION | ||||||
Date: July 2, 2019 | By: | /s/ Steven G. Mahon | ||||
Steven G. Mahon | ||||||
Executive Vice President, General Counsel and Corporate Secretary |
3